Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Diabetic Lancing Device Companies

Diabetic lancing devices are essential tools for individuals with diabetes to obtain blood samples for glucose monitoring. These devices use lancets to prick the skin, allowing users to measure their blood glucose levels. Companies in the diabetic lancing device market produce and distribute these devices, aiming to provide convenient and less painful solutions for blood sampling.

Diabetic lancing device market

Latest Diabetic lancing device Companies Updates

Owen Mumford acquires Jiangsu Hengrui Medicine's diabetes care business: This December 2023 deal strengthens Owen Mumford's presence in the Chinese market, a key driver of market growth.

Terumo Corporation partners with HTL-Strefa S.A.: This November 2023 collaboration aims to expand Terumo's reach in the European lancing device market, leveraging HTL-Strefa's expertise and distribution network.

Bayer launches Breeze® 2 lancing device with ComfortGlide™ technology: This July 2023 launch offers a user-friendly option with features like pre-loaded lancets and adjustable depth settings for a more comfortable lancing experience.

Roche introduces Accu-Chek® Guide lancing device with built-in blood ketone testing: This December 2023 innovation allows diabetics to measure both blood glucose and ketones with a single finger prick, providing a more comprehensive picture of their diabetes management.

Ypsomed develops smart lancing devices with integrated sensors: These innovative devices have the potential to improve insulin dosing accuracy and diabetes management through data collection and insights.

List of Diabetic lancing device Key companies in the market:

B. Braun Melsungen AG

Terumo Corporation

Becton Dickinson

Sanofi

F. Hoffmann-La Roche AG

Bayer AG

Novo Nordisk A S

Eli Lilly and Company

Owen Mumford Ltd

Medtronic

Diabetic Lancing Device Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.